These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 27179628

  • 1. Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.
    Chaudhary N, Kabra M, Gulati S, Gupta YK, Pandey RM, Bhatia BD.
    BMC Pediatr; 2016 May 14; 16():66. PubMed ID: 27179628
    [Abstract] [Full Text] [Related]

  • 2. Clinical relevance of genetic polymorphism in CYP2C9 gene to pharmacodynamics and pharmacokinetics of phenytoin in epileptic patients: validatory pharmacogenomic approach to pharmacovigilance.
    Kousar S, Wafai ZA, Wani MA, Jan TR, Andrabi KI.
    Int J Clin Pharmacol Ther; 2015 Jul 14; 53(7):504-16. PubMed ID: 25943175
    [Abstract] [Full Text] [Related]

  • 3. Association of CYP2C9 polymorphisms with phenytoin toxicity in Indian patients.
    Thakkar AN, Bendkhale SR, Taur SR, Gogtay NJ, Thatte UM.
    Neurol India; 2012 Jul 14; 60(6):577-80. PubMed ID: 23287317
    [Abstract] [Full Text] [Related]

  • 4. The effect of genetic polymorphism of cytochrome P450 CYP2C9 on phenytoin dose requirement.
    van der Weide J, Steijns LS, van Weelden MJ, de Haan K.
    Pharmacogenetics; 2001 Jun 14; 11(4):287-91. PubMed ID: 11434505
    [Abstract] [Full Text] [Related]

  • 5. Influence of CYP2C9 genetic polymorphism and undernourishment on plasma-free phenytoin concentrations in epileptic patients.
    Ramasamy K, Narayan SK, Shewade DG, Chandrasekaran A.
    Ther Drug Monit; 2010 Dec 14; 32(6):762-6. PubMed ID: 21068649
    [Abstract] [Full Text] [Related]

  • 6. The effect of polymorphic metabolism enzymes on serum phenytoin level.
    Ozkaynakci A, Gulcebi MI, Ergeç D, Ulucan K, Uzan M, Ozkara C, Guney I, Onat FY.
    Neurol Sci; 2015 Mar 14; 36(3):397-401. PubMed ID: 25311916
    [Abstract] [Full Text] [Related]

  • 7. [Development of rapid genotyping methods for single nucleotide polymorphisms of cytochrome P450 2C9 (CYP2C9) and cytochrome P450 2C19 (CYP2C19) and their clinical application in pediatric patients with epilepsy].
    Yamamoto Y, Takahashi Y, Nishimura S, Ikumi Y, Mishima N, Kagawa Y.
    Yakugaku Zasshi; 2011 Mar 14; 131(5):809-15. PubMed ID: 21532277
    [Abstract] [Full Text] [Related]

  • 8. Impact of Genetic Polymorphisms on Phenytoin Pharmacokinetics and Clinical Outcomes in the Middle East and North Africa Region.
    Dagenais R, Wilby KJ, Elewa H, Ensom MHH.
    Drugs R D; 2017 Sep 14; 17(3):341-361. PubMed ID: 28748348
    [Abstract] [Full Text] [Related]

  • 9. [Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration].
    Huang Y, Yang JF, Qi XL, Wang YQ, Wang WZ, Chen B.
    Zhonghua Yi Xue Za Zhi; 2004 Oct 17; 84(20):1686-9. PubMed ID: 15569425
    [Abstract] [Full Text] [Related]

  • 10. CYP2C9, CYP2C19, ABCB1 genetic polymorphisms and phenytoin plasma concentrations in Mexican-Mestizo patients with epilepsy.
    Ortega-Vázquez A, Dorado P, Fricke-Galindo I, Jung-Cook H, Monroy-Jaramillo N, Martínez-Juárez IE, Familiar-López I, Peñas-Lledó E, LLerena A, López-López M.
    Pharmacogenomics J; 2016 Jun 17; 16(3):286-92. PubMed ID: 26122019
    [Abstract] [Full Text] [Related]

  • 11. Influenza immunization does not predominantly alter levels of phenytoin, and cytochrome P-450 enzymes in epileptic patients receiving phenytoin monotherapy.
    Soontornpun A, Manoyana N, Apaijai N, Pinyopornpanish K, Pinyopornpanish K, Nadsasarn A, Tanprawate S, Chattipakorn N, Chattipakorn SC.
    Epilepsy Res; 2020 Nov 17; 167():106471. PubMed ID: 33007725
    [Abstract] [Full Text] [Related]

  • 12. CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.
    Franco V, Perucca E.
    Expert Opin Drug Metab Toxicol; 2015 Nov 17; 11(8):1269-79. PubMed ID: 26037375
    [Abstract] [Full Text] [Related]

  • 13. Association analysis of CYP2C9*3 and phenytoin-induced severe cutaneous adverse reactions (SCARs) in Thai epilepsy children.
    Suvichapanich S, Jittikoon J, Wichukchinda N, Kamchaisatian W, Visudtibhan A, Benjapopitak S, Nakornchai S, Manuyakorn W, Mahasirimongkol S.
    J Hum Genet; 2015 Aug 17; 60(8):413-7. PubMed ID: 25994870
    [Abstract] [Full Text] [Related]

  • 14. CYP2C9 polymorphism in patients with epilepsy: genotypic frequency analyzes and phenytoin adverse reactions correlation.
    Twardowschy CA, Werneck LC, Scola RH, De Paola L, Silvado CE.
    Arq Neuropsiquiatr; 2011 Apr 17; 69(2A):153-8. PubMed ID: 21537551
    [Abstract] [Full Text] [Related]

  • 15. Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting.
    Lee SY, Lee ST, Kim JW.
    J Biochem Mol Biol; 2007 May 31; 40(3):448-52. PubMed ID: 17562299
    [Abstract] [Full Text] [Related]

  • 16. Association of polymorphisms of CYP2C9, CYP2C19, and ABCB1, and activity of P-glycoprotein with response to anti-epileptic drugs.
    Taur SR, Kulkarni NB, Gandhe PP, Thelma BK, Ravat SH, Gogtay NJ, Thatte UM.
    J Postgrad Med; 2014 May 31; 60(3):265-9. PubMed ID: 25121365
    [Abstract] [Full Text] [Related]

  • 17. A meta-analysis of effects of CYP2C9 and CYP2C19 polymorphisms on phenytoin pharmacokinetic parameters.
    Kanjanasilp J, Sawangjit R, Phanthaisong S, Borihanthanawuth W.
    Pharmacogenomics; 2021 Jul 31; 22(10):629-640. PubMed ID: 34060344
    [Abstract] [Full Text] [Related]

  • 18. Genetic polymorphism of the CYP2C subfamily and its effect on the pharmacokinetics of phenytoin in Japanese patients with epilepsy.
    Odani A, Hashimoto Y, Otsuki Y, Uwai Y, Hattori H, Furusho K, Inui K.
    Clin Pharmacol Ther; 1997 Sep 31; 62(3):287-92. PubMed ID: 9333104
    [Abstract] [Full Text] [Related]

  • 19. The association between CYP2C9/2C19 polymorphisms and phenytoin maintenance doses in Asian epileptic patients: A systematic review and meta-analysis
.
    Liao K, Liu Y, Ai CZ, Yu X, Li W.
    Int J Clin Pharmacol Ther; 2018 Jul 31; 56(7):337-346. PubMed ID: 29628024
    [Abstract] [Full Text] [Related]

  • 20. Clinical significance of CYP2C9-status guided valproic acid therapy in children.
    Bűdi T, Tóth K, Nagy A, Szever Z, Kiss Á, Temesvári M, Háfra E, Garami M, Tapodi A, Monostory K.
    Epilepsia; 2015 Jun 31; 56(6):849-55. PubMed ID: 25967074
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.